BR0209221A - Pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma - Google Patents

Pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma

Info

Publication number
BR0209221A
BR0209221A BR0209221-2A BRPI0209221A BR0209221A BR 0209221 A BR0209221 A BR 0209221A BR PI0209221 A BRPI0209221 A BR PI0209221A BR 0209221 A BR0209221 A BR 0209221A
Authority
BR
Brazil
Prior art keywords
sugar
manufacturing process
sucking
lozenge
lozenged
Prior art date
Application number
BR0209221-2A
Other languages
English (en)
Inventor
Pierre Dupinay
Robert Torres
Christine Capon
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR0209221A publication Critical patent/BR0209221A/pt
Publication of BRPI0209221B1 publication Critical patent/BRPI0209221B1/pt
Publication of BRPI0209221B8 publication Critical patent/BRPI0209221B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Road Signs Or Road Markings (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)

Abstract

"PASTILHA MEDICAMENTOSA DE AçúCAR COZIDO PARA CHUPAR E PROCESSO DE FABRICAçãO DA MESMA". Pastilha medicamentosa de açúcar cozido para chupar, de consistência sólida, destinada a se dissolver na cavidade bucal, compreendendo pelo menos um princípio ativo, caracterizada em que ela compreende, por outro lado, pelo menos um agente matricial permitindo retardar a liberação do ou dos princípios ativos que permanece, então, em contato prolongado com a esfera bucofaríngea, o tempo de dissolução na cavidade bucal sendo de, pelo menos, 15 minutos.
BRPI0209221A 2001-04-25 2002-04-25 pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma BRPI0209221B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0105554A FR2823974B1 (fr) 2001-04-25 2001-04-25 Pastille medicamenteuse a liberation lente du principe actif
FR01/05554 2001-04-25
PCT/FR2002/001421 WO2002085334A1 (fr) 2001-04-25 2002-04-25 Pastille medicamenteuse a liberation lente du principe actif

Publications (3)

Publication Number Publication Date
BR0209221A true BR0209221A (pt) 2004-06-15
BRPI0209221B1 BRPI0209221B1 (pt) 2018-03-13
BRPI0209221B8 BRPI0209221B8 (pt) 2021-07-27

Family

ID=8862665

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209221A BRPI0209221B8 (pt) 2001-04-25 2002-04-25 pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma

Country Status (12)

Country Link
US (1) US8545870B2 (pt)
EP (3) EP2184057B1 (pt)
AT (1) ATE465721T1 (pt)
BR (1) BRPI0209221B8 (pt)
CA (1) CA2445200C (pt)
CY (1) CY1117370T1 (pt)
DE (1) DE60236149D1 (pt)
DK (2) DK2184057T3 (pt)
ES (2) ES2565464T3 (pt)
FR (1) FR2823974B1 (pt)
PT (1) PT1383484E (pt)
WO (1) WO2002085334A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
UA112974C2 (uk) * 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130206150A1 (en) * 2012-02-10 2013-08-15 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
FR2993778B1 (fr) 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US9351936B2 (en) * 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN108684938A (zh) * 2018-04-16 2018-10-23 广州智特奇生物科技股份有限公司 一种植物精油包被液、微胶囊植物精油及其制备方法
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
CA3160750A1 (en) 2019-12-09 2021-06-17 Anthony Richard Gerardi Oral product comprising a cannabinoid
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144915A (en) * 1966-11-24 1969-03-12 Armour Pharma Improvements in or relating to pastille formulations
US5785989A (en) * 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
GB8518927D0 (en) * 1985-07-26 1985-09-04 Vincent Processes Ltd Tablets
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
DE19536394A1 (de) * 1995-09-29 1997-04-03 Basf Ag Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
DE19606968C2 (de) * 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
ATE247951T1 (de) * 1996-05-13 2003-09-15 Novartis Consumer Health Sa Mundfreisetzungssystem
TW474824B (en) * 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
IT1297233B1 (it) * 1996-10-29 1999-08-09 Montefarmaco Spa Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica
US5942244A (en) * 1997-07-31 1999-08-24 Farmo-Nat Ltd. Local oral herbal slow release tablets
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form

Also Published As

Publication number Publication date
BRPI0209221B1 (pt) 2018-03-13
US20060171994A1 (en) 2006-08-03
WO2002085334A1 (fr) 2002-10-31
CA2445200C (fr) 2011-09-06
FR2823974A1 (fr) 2002-10-31
EP1383484A1 (fr) 2004-01-28
PT1383484E (pt) 2010-05-27
DK2184057T3 (en) 2016-04-18
DK1383484T3 (da) 2010-06-07
DE60236149D1 (de) 2010-06-10
ATE465721T1 (de) 2010-05-15
CA2445200A1 (fr) 2002-10-31
ES2565464T3 (es) 2016-04-04
ES2340761T3 (es) 2010-06-09
EP2184057B1 (fr) 2016-01-13
US8545870B2 (en) 2013-10-01
BRPI0209221B8 (pt) 2021-07-27
EP2184057A1 (fr) 2010-05-12
EP2269588A1 (fr) 2011-01-05
CY1117370T1 (el) 2017-04-26
EP1383484B1 (fr) 2010-04-28
FR2823974B1 (fr) 2004-10-15

Similar Documents

Publication Publication Date Title
BR0209221A (pt) Pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma
BR0112495A (pt) Forma de dosagem, processo para a produção de uma forma de dosagem e uso da forma de dosagem
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
AR027902A1 (es) Preparacion medicamentosa plana para la administracion transmucosa de oxicodona o un principio activo similar en la cavidad bucal, para su aplicacion en el tratamiento contra el dolor y la adiccion
BR9811803A (pt) Comprido multiparticular aperfeiçoado de dissolução rápida
GT199900164AA (es) Pelicula consumible que se adhiere y se disuelve en la boca de un consumidor.
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DK0939613T3 (da) Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning
WO2007018622A3 (en) Vaginal treatment composition
BR0212975A (pt) Elemento de liberação de dosagem controlada, e, métodos para a liberação de pelo menos um primeiro agente ativo para dentro do rúmen de um animal ruminante, para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante e para a alteração do estado fisiológico de um animal ruminante
NO20031622L (no) Medisinske blandinger som raskt desintegrerer i munnhulen og fremgangsmåtefor fremstilling av samme
SI1680128T1 (sl) Mio-inozitol heksafosfat za topično uporabo
ATA2332000A (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
BR0005632A (pt) Unidade de sabão de dose única e método
BR0012444A (pt) Composições de pó seco
AR048050A1 (es) Formas de administracion masticables, no comprimidas, dosificadas individualmente
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
BR9812385A (pt) Formulações parasiticidas
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
MXPA05005911A (es) Utilizacion del acido docosahexaenoico como sustancia activa para el tratamiento de la lipodistrofia.
JP2001316293A5 (pt)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/04/2002, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2720 DE 23/02/2023 POR TER SIDO INDEVIDA, UMA VEZ QUE A VALIDADE DA PATENTE FOI ALTERADA PARA 20 ANOS CONTADOS DO DEPOSITO, CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 25/04/2022